Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
23 03 2021
Historique:
received: 10 09 2020
accepted: 24 02 2021
entrez: 24 3 2021
pubmed: 25 3 2021
medline: 11 8 2021
Statut: epublish

Résumé

Idiopathic pulmonary fibrosis (IPF) is a fatal disorder characterised by progressive, destructive lung scarring. Despite substantial progress, the genetic determinants of this disease remain incompletely defined. Using whole genome and whole exome sequencing data from 752 individuals with sporadic IPF and 119,055 UK Biobank controls, we performed a variant-level exome-wide association study (ExWAS) and gene-level collapsing analyses. Our variant-level analysis revealed a novel association between a rare missense variant in SPDL1 and IPF (NM_017785.5:g.169588475 G > A p.Arg20Gln; p = 2.4 × 10

Identifiants

pubmed: 33758299
doi: 10.1038/s42003-021-01910-y
pii: 10.1038/s42003-021-01910-y
pmc: PMC7988141
doi:

Substances chimiques

Cell Cycle Proteins 0
SPDL1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

392

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Références

Chest. 2019 Sep;156(3):477-485
pubmed: 30978332
Nat Cell Biol. 2018 Jul;20(7):800-810
pubmed: 29915359
Mol Biol Cell. 2010 Jun 15;21(12):1968-81
pubmed: 20427577
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Cell Biol. 2017 Apr 3;216(4):943-960
pubmed: 28320824
Genet Epidemiol. 2010 Dec;34(8):816-34
pubmed: 21058334
Eur Respir Rev. 2012 Dec 1;21(126):355-61
pubmed: 23204124
Am J Respir Cell Mol Biol. 2015 Feb;52(2):217-31
pubmed: 25029475
Am J Respir Crit Care Med. 2017 Jul 1;196(1):82-93
pubmed: 28099038
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23625-23635
pubmed: 31690663
Am J Respir Crit Care Med. 2020 Mar 1;201(5):564-574
pubmed: 31710517
N Engl J Med. 2018 May 10;378(19):1811-1823
pubmed: 29742380
Nucleic Acids Res. 2014 May;42(9):e75
pubmed: 24609383
Biol Open. 2018 May 29;7(5):
pubmed: 29685992
BMJ Open Respir Res. 2014 Dec 10;1(1):e000057
pubmed: 25553246
Am J Hum Genet. 2020 May 7;106(5):659-678
pubmed: 32386536
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
N Engl J Med. 2011 Apr 21;364(16):1503-12
pubmed: 21506741
Lancet Respir Med. 2018 Aug;6(8):603-614
pubmed: 29891356
Annu Rev Med. 2019 Jan 27;70:211-224
pubmed: 30691371
Genome Res. 2017 Oct;27(10):1715-1729
pubmed: 28864458

Auteurs

Ryan S Dhindsa (RS)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Johan Mattsson (J)

Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Abhishek Nag (A)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Quanli Wang (Q)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Louise V Wain (LV)

Genetic Epidemiology Group, Department of Health Sciences George Davies Centre, University of Leicester, Leicester, UK.
National Institute for Health Research, Leicester Respiratory Biomedical Research Centre, Glenfield Hospital, Leicester, UK.

Richard Allen (R)

Genetic Epidemiology Group, Department of Health Sciences George Davies Centre, University of Leicester, Leicester, UK.

Eleanor M Wigmore (EM)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Kristina Ibanez (K)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Dimitrios Vitsios (D)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Sri V V Deevi (SVV)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Sebastian Wasilewski (S)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Maria Karlsson (M)

Lung Regeneration, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Glenda Lassi (G)

Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Henric Olsson (H)

Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Daniel Muthas (D)

Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Susan Monkley (S)

Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Alex Mackay (A)

Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Lynne Murray (L)

Lung Regeneration, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Simon Young (S)

Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK.

Carolina Haefliger (C)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Toby M Maher (TM)

Royal Brompton Hospital, London, UK.
Hastings Centre for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Maria G Belvisi (MG)

National Heart and Lung Institute, Imperial College, London, UK.
Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Respiratory Pharmacology Group, London, UK.

Gisli Jenkins (G)

Respiratory Research Unit, Division of Respiratory Medicine, University of Nottingham, Nottingham, UK.
National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.

Philip L Molyneaux (PL)

Royal Brompton Hospital, London, UK. p.molyneaux@imperial.ac.uk.
National Heart and Lung Institute, Imperial College, London, UK. p.molyneaux@imperial.ac.uk.

Adam Platt (A)

Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Adam.Platt@astrazeneca.com.

Slavé Petrovski (S)

Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. slav.petrovski@astrazeneca.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH